Health science reports · 2026
Epidemiology and Burden of Gallbladder and Biliary Diseases and the Socioeconomic Factors in the Region of Middle East and North Africa, 1990-2021: Estimates From the Global Burden of Disease 2021 Study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Isari Zahra, Azizi Ghiasabadi Melika, Gharihe Mohammad Amin, Mashayekhi Amir, Khashaveh Ali, Dabiri Esmaeil, Bahrampour Saeed, Farsi Arman, Izadpanah Kamiar, Pourghadamyari Hossein, Sharifi Hamid, Eslami Omid, Nejadghaderi Seyed Aria
Аннотация
BACKGROUND AND AIMS: As common disorders affecting the digestive system, gallbladder and biliary diseases present a significant health issue. This research aimed to assess the burden of these conditions in the Middle East and North Africa (MENA) region over the period of 1990 to 2021. Furthermore, we investigated the epidemiological characteristics of these diseases in relation to age, sex, and the Socio-demographic Index (SDI).
METHODS: Drawing from the Global Burden of Disease (GBD) study 2021, we extracted data on the prevalence, incidence, and disability-adjusted life years (DALYs) linked with gallbladder and biliary disease for 21 countries in the MENA region from 1990 to 2021. The results were presented as both absolute numbers and rates per 100,000 people, accompanied by their corresponding 95% uncertainty intervals (UIs). The association between disease burden and SDI was evaluated using smoothing spline models.
RESULTS: In 2021, the MENA region documented 4.8 million new cases of gallbladder and biliary diseases, with an age-standardized incidence rate of 808.9 per 100,000 population, which represents a 5.0% reduction since 1990. The prevalence increased to 15.4 million cases, with an age-standardized rate of 2807.5 per 100,000, marking a 7.9% decrease. The overall disease burden, quantified in DALYs, reached 437.1 thousand, with an age-standardized rate of 85.7 per 100,000, signifying a 16.6% decline. Afghanistan estimated the highest DALY rates, while Oman had the lowest. A more pronounced burden was observed in females across all age brackets. An inverse correlation was identified between disease burden and SDI.
CONCLUSION: Gallbladder and biliary diseases continue to be a public health challenge, particularly affecting women, the elderly, and nations with lower SDI levels. It is imperative for each country to develop healthcare systems and preventive measures that are tailored to its specific context.
METHODS: Drawing from the Global Burden of Disease (GBD) study 2021, we extracted data on the prevalence, incidence, and disability-adjusted life years (DALYs) linked with gallbladder and biliary disease for 21 countries in the MENA region from 1990 to 2021. The results were presented as both absolute numbers and rates per 100,000 people, accompanied by their corresponding 95% uncertainty intervals (UIs). The association between disease burden and SDI was evaluated using smoothing spline models.
RESULTS: In 2021, the MENA region documented 4.8 million new cases of gallbladder and biliary diseases, with an age-standardized incidence rate of 808.9 per 100,000 population, which represents a 5.0% reduction since 1990. The prevalence increased to 15.4 million cases, with an age-standardized rate of 2807.5 per 100,000, marking a 7.9% decrease. The overall disease burden, quantified in DALYs, reached 437.1 thousand, with an age-standardized rate of 85.7 per 100,000, signifying a 16.6% decline. Afghanistan estimated the highest DALY rates, while Oman had the lowest. A more pronounced burden was observed in females across all age brackets. An inverse correlation was identified between disease burden and SDI.
CONCLUSION: Gallbladder and biliary diseases continue to be a public health challenge, particularly affecting women, the elderly, and nations with lower SDI levels. It is imperative for each country to develop healthcare systems and preventive measures that are tailored to its specific context.